drugset / Trial / NCT00511316

Trial of Montelukast in Eosinophilic Esophagitis

NCT00511316

Phase 1 Completed 41 enrolled Mayo Clinic Merck Sharp & Dohme LLC · collab
RandomizedSingle-groupTriple-blindTreatment

Summary

Evaluate clinical effectiveness of oral montelukast compared to placebo on prevention of dysphagia and food impaction in patients with EE. Also evaluate tolerance and safety of oral montelukast in treatment of EE.

Timeline

Start
2007-08
Primary completion
2015-09
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 20 mg Oral